CHRAC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.097000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.308400E-01
Normal-vs-Stage2
4.916100E-03
Normal-vs-Stage3
4.452800E-01
Normal-vs-Stage4
2.909000E-01
Stage1-vs-Stage2
9.015400E-01
Stage1-vs-Stage3
1.242780E-01
Stage1-vs-Stage4
8.817600E-01
Stage2-vs-Stage3
1.255030E-01
Stage2-vs-Stage4
7.958400E-01
Stage3-vs-Stage4
1.357650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.461600E-03
Normal-vs-AfricanAmerican
9.704000E-01
Normal-vs-Asian
1.075800E-01
Caucasian-vs-AfricanAmerican
3.220200E-01
Caucasian-vs-Asian
7.920000E-01
AfricanAmerican-vs-Asian
2.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.337800E-03
Normal-vs-Female
4.480400E-01
Male-vs-Female
5.709600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.971200E-01
Normal-vs-Age(41-60Yrs)
4.952800E-04
Normal-vs-Age(61-80Yrs)
3.107500E-02
Normal-vs-Age(81-100Yrs)
1.161980E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.837570E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.646200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.289200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.594200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.764000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.170600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.511440E-01
Normal-vs-Daily Drinker
4.152400E-02
Normal-vs-Weekly Drinker
3.865200E-01
Normal-vs-Occasional Drinker
3.183300E-03
Normal-vs-Social Drinker
4.025400E-01
Non Drinker-vs-Daily Drinker
4.337600E-01
Non Drinker-vs-Weekly Drinker
9.640400E-01
Non Drinker-vs-Occasional Drinker
2.876300E-02
Non Drinker-vs-Social Drinker
8.558400E-01
Daily Drinker-vs-Weekly Drinker
4.368200E-01
Daily Drinker-vs-Occasional Drinker
1.707370E-01
Daily Drinker-vs-Social Drinker
3.129000E-01
Weekly Drinker-vs-Occasional Drinker
3.772400E-02
Weekly Drinker-vs-Social Drinker
7.985000E-01
Occasional Drinker-vs-Social Drinker
2.314400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.986800E-01
Normal-vs-Grade 2
1.559020E-01
Normal-vs-Grade 3
3.056800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.954400E-01
Grade 1-vs-Grade 3
1.782180E-01
Grade 1-vs-Grade 4
4.986800E-01
Grade 2-vs-Grade 3
3.279000E-01
Grade 2-vs-Grade 4
1.559020E-01
Grade 3-vs-Grade 4
3.056800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.391400E-01
Normal-vs-NonDiabetic
2.017600E-03
Diabetic-vs-NonDiabetic
7.955900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.183500E-02
Normal-vs-NoPancreatitis
5.304800E-03
Pancreatitis-vs-NoPancreatitis
2.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.303700E-02
Normal-vs-N1
7.020300E-03
N0-vs-N1
9.398400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.57630000002995E-06
Normal-vs-TP53-NonMutant
2.479800E-01
TP53-Mutant-vs-TP53-NonMutant
4.32009999995486E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
